Simpson Grierson has leading experience in all aspects of patent law.

Our highly skilled team can provide services for domestic and international patent matters.

Our patent law experts advise a number of multi-national companies in relation to patent licensing and disputes, in particular within the pharmaceutical, medical device, and animal health sectors.

As well as providing strategic advice in relation to Pharmac tender and licensing strategies, Simpson Grierson has recently advised in leading patent disputes and appeals.

Work Highlights

Lucas v Peterson

Our advice included an application to the High Court to amend patent, strike out of counterclaim for unjustified threats of patent infringement proceedings, and High Court and Court of Appeal strike out and appeals following contested settlement of the litigation.

Novartis Animal Health 

We advised on the acquisition of patents and other intellectual property assets from a New Zealand animal health company, and related licensing and supply arrangements.


We advised on substantial patent infringement litigation with Astra Zeneca, and intellectual property issues relating to PHARMAC arrangements.

University of Otago 

Our work has included advice on intellectual property protection and commercialisation strategy and related contractual arrangements.

Neuren Pharmaceuticals

Our work has included advising on patent issues relating to the initial public offering of shares in Australia and New Zealand and listing on ASX, and on various intellectual property issues.

Our Experts